Application of MALDI-TOF Mass Spectrometry for Rapid Pathogen Identification in an Era of ‘One Medicine-One Health’ Microbiology T

Total Page:16

File Type:pdf, Size:1020Kb

Application of MALDI-TOF Mass Spectrometry for Rapid Pathogen Identification in an Era of ‘One Medicine-One Health’ Microbiology T Poster P-2331 ECCMID, 2012 Application of MALDI-TOF Mass Spectrometry for Rapid Pathogen Identification in an Era of ‘One Medicine-One Health’ Microbiology T. Fritsche1,3, B. Olson2, C. Pike1, M. Stemper1,3, F. Moore1, J. Meece2,3, S. Shukla2,3, T. Novicki1 Marshfield Clinic, Marshfield, WI, USA1. Marshfield Clinic Res. Fndn., Marshfield, WI ,USA2. Univ. of Wisconsin, La Crosse, WI, USA3 REVISED ABSTRACT* INTRODUCTION OBJECTIVES: To evaluate the utility of MALDI-TOF mass The majority of human bacterial and fungal pathogens (up to 60% by some assessments) also produce disease in Table 2. Comparison (%) of genus- and species-level spectrometry (MS) as a single platform for pathogen various animal species. The remainder comprise a variety of species that are more specific pathogens for the particular identifications using MBT and Standard Lab Methods (SLM). identification (ID) in a regional laboratory practice host, and/or that only cross species barriers occasionally (zoonoses). Differences in laboratory practices between routinely performing analyses on human- and animal- human and veterinary testing laboratories relate to the differences in disease-producing agents, identification schema, Human Source Animal Source Overall source clinical specimens. Integration of signature- different antimicrobial agents and different guidance documents. SLM Genus Level ID 94.1 88.2 91.2 based proteomic analyses into medical and veterinary SLM Species Level ID 70.0 51.8 60.9 laboratories may enhance ID performance, improve Despite such differences, the increasing recognition that many of our core pathogens increasingly display similar MBT Genus Level ID 98.8 95.4 97.1 clinical service and epidemiologic research, and antimicrobial resistance phenotypes, and that we readily share these pathogens with our companion and food-source promote cross-disciplinary collaboration promulgated animals, behooves us to consider simultaneously the emergence and significance of these ‘shared’ pathogens in both MBT Species Level ID 94.4 87.2 90.8 by the ‘One Medicine-One Health’ concept (Veterinaria environments. Such recognition of the need for greater integration of human and animal health concerns has been the Italiana 45[1]; 2009). Here we demonstrate that MS can impetus for some years in the promulgation of the ‘One Medicine-One Health’ concept by the medical, veterinary and be as rapid, accurate and cost-effective when testing public health professions (Kaplan, 2009; Kahn, 2009). The lack of opportunity to capitalize on this concept is a practical isolates of veterinary importance as when testing matter; whether the human and animal laboratory testing communities are prepared to assist each other with this CONCLUSIONS human-source isolates in the same laboratory setting. initiative remains to be determined, but the benefits are considerable (Cardiff, 2008). •Use of mass spectrometry-generated signature-based proteomic analyses for pathogen identification is rapidly METHODS: Clinically significant pathogens (n=1,502) Technology is one area where medical and veterinary professions strongly complement one another. The recent gaining acceptance among human and veterinary from humans (573), and domestic and exotic animals introduction of MALDI-TOF mass spectrometry is displaying great promise for the rapid, accurate and cost-effective diagnostic microbiology laboratories. (929) were analyzed by MS and included identification of bacterial and fungal pathogens. Integration of this proteomic signature-based approach into (human/animal isolates): staphylococci (112/193), contemporary laboratory practice holds great promise in revolutionizing clinical microbiology, as is evidenced by recent •The rapidity and accuracy of the MBT for human streptococci (61/112), enterococci (54/109), other applications in both human (Bizzini, 2012; Boggs, 2012; Carbonnelle, 2011; van Veen, 2012) and veterinary (Ahrholdt, (98.8%/94.4%, genus-/species-level, respectively) and Gram-positive cocci (36/1), Gram-positive bacilli 2011; Hijazin, 2011; Kuhnert, 2012; Vila, 2012) medicine. The improvement in laboratory turn-around time from 48-96 animal (95.4%/87.2%) pathogen identifications is (18/56), Enterobacteriaceae (147/252), Pseudomonas to 24 hours for pathogen identification can be expected to have real-time benefits in terms of earlier, targeted unsurpassed compared with traditional biochemical aeruginosa (61/69), other nonfermentative bacilli antimicrobial selection, detection of emerging diseases, and permitting of quarantine to be instituted sooner. methods. (56/49), Pasturella spp. (1/51), Actinobacillus spp. (0/9), and other Gram-negative bacilli (27/28). Isolates were In this study we evaluated the utility of MALDI-TOF mass spectrometry as a single platform for rapid pathogen •Infection and antimicrobial resistance health threats in identified by standard biochemical methods, and by MS identification in a regional USA laboratory practice routinely performing analyses on both human and animal-source humans and animals are often shared between these (Bruker Daltonics MALDI Biotyper™ v3.0) according to specimens. populations, and local and regional diagnostic the manufacturer’s recommendations and validation laboratories serve a critical public health sentinel algorithms. Table 1. Identification of 1,502 human- and animal-source isolates (year 2010) tested by MBT (Bruker Daltonics MALDI Biotyper™ v3.0). function in detecting their presence. RESULTS: Overall, MS provided species- and genus-level IDs, respectively, for 90.8% and 97.1% of 1,502 tested % Species Level ID % Genus Level ID % No ID •Utilization of MS for identification of pathogens recovered from human and animal specimens facilitates isolates. Among human and animal-source isolates, Isolate Groups (nspecies) nHuman nAnimal Human Animal Human Animal Human Animal respectively, MS identified 94.4%/87.2% to species- Coagulase-negative Staphylococcus (14) 52 48 88.5 62.5 9.6 37.5 1.9 0 and enhances the likelihood of detecting emerging level, 98.8%/95.4% to genus-level and 1.2%/4.6%, no Staphylococcus epidermidis 29 6 100 100 0 0 0 0 pathogens in both populations, and supports a key Staphylococcus felis 0 13 0 15.4 0 84.6 0 0 component of laboratory infrastructure essential for identification (not in database); compared with MS, Staphylococcus haemolyticus 2 2 100 0 0 100 0 0 promotion of the ‘One Medicine/One Health’ concept. standard ID approaches identified 70.0%/51.8% to Staphylococcus saprophyticus 7 0 71.4 0 28.6 0 0 0 species-level and 94.1%/88.2% to genus-level. Staphylococcus schleiferi 0 22 0 77.3 0 22.7 0 0 Discordant or missing IDs were present in 5.9% of Coagulase-positive Staphylococcus (4) 1 124 100 84.7 0 14.5 0 0.8 Staphylococcus intermedius group 1 124 100 84.7 0 14.5 0 0.8 human and 11.8% of animal source isolates. Staphylococcus aureus 59 21 100 100 0 0 0 0 Enterococcus species (8) 54 109 100 100 0 0 0 0 SELECTED REFERENCES CONCLUSION: Emerging infection health threats are Enterococcus faecalis 47 83 100 100 0 0 0 0 often zoonotic in origin, and local and regional Enterococcus faecium 6 19 100 100 0 0 0 0 Ahrholdt J, Murugaiyan J, Straubinger RK, Jagielski T, diagnostic laboratories serve a critical sentinel function Escherichia coli 49 104 100 100 0 0 0 0 Roesler U. Epidemiological analysis of worldwide bovine, Klebsiella species (3) 21 22 100 100 0 0 0 0 in detecting their presence. Utilization of MS for ID of canine and human clinical Prototheca isolates by PCR Klebsiella oxytoca 6 6 100 100 0 0 0 0 genotyping and MALDI-TOF mass spectrometry proteomic pathogens recovered from human and animal Klebsiella pneumoniae 14 16 100 100 0 0 0 0 specimens facilitates and enhances the likelihood of Proteus mirabilis 10 39 100 100 0 0 0 0 phenotyping. Med Mycol. 2011 Sep 12. [Epub ahead of detecting emerging pathogens in both populations. The Other Enterobacteriaceae (24) 67 87 95.5 92.0 4.5 4.6 0 3.4 print] accuracy and rapidity of MS technology for human Citrobacter species 13 13 92.3 76.9 7.7 7.7 0 15.4 Enterobacter species 15 12 93.3 100 6.7 0 0 0 (94.4%/98.8%, species-/genus-level) and animal (87.2%/ Bizzini A, Greub G. Matrix-assisted laser desorption Morganella morganii 6 7 100 100 0 0 0 0 ionization time-of-flight mass spectrometry, a revolution in 95.4%) pathogen IDs, supports a key component of Providencia species 3 5 100 100 0 0 0 0 laboratory infrastructure essential for promotion of the Salmonella species 10 16 100 93.8 0 6.2 0 0 clinical microbial identification. Clin Microbiol Infect. 2010 ‘One Medicine/One Health’ concept. Pseudomonas aeruginosa 61 69 100 100 0 0 0 0 Nov;16(11):1614-9. Other Non-fermentative GNB (38) 56 49 89.3 71.4 7.1 24.5 3.6 4.1 Achromobacter xylosoxidans 5 2 100 100 0 0 0 0 Boggs SR, Cazares LH, Drake RR. Characterisation of a *Revised to include additional isolates. Acinetobacter species 12 9 91.7 88.9 8.3 0 0 11.1 Other Pseudomonas species 10 14 80.0 57.1 0 42.9 20.0 0 Staphylococcus aureus USA300 protein signature using Stenotrophomonas maltophilia 17 6 100 83.3 0 16.7 0 0 matrix-assisted laser desorption/ionization time-of-flight Pasturella/Actinobacillus spp. (7) 1 60 100 78.3 0 8.3 0 13.3 mass spectrometry. J Med Microbiol. 2012 Feb 9. [Epub Actinobacillus species 0 11 0 72.7 0 9.1 0 18.2 ahead of print] Pasteurella canis 0 19 0 84.2 0 15.8 0 0 Pasteurella multocida 1 22 100 81.8 0 4.6 0 13.6 Gram-positive bacilli (27) 18 56 72.2 42.9 16.7 23.2 11.1 33.9 Carbonnelle E, Mesquita C, Bille E, Day N, Dauphin B, MATERIALS AND METHODS Arcanobacterium pyogenes 0 14 0 92.9 0 7.1 0 0 Beretti JL, Ferroni A, Gutmann L, Nassif X.
Recommended publications
  • ( 12 ) United States Patent
    US009956282B2 (12 ) United States Patent ( 10 ) Patent No. : US 9 ,956 , 282 B2 Cook et al. (45 ) Date of Patent: May 1 , 2018 ( 54 ) BACTERIAL COMPOSITIONS AND (58 ) Field of Classification Search METHODS OF USE THEREOF FOR None TREATMENT OF IMMUNE SYSTEM See application file for complete search history . DISORDERS ( 56 ) References Cited (71 ) Applicant : Seres Therapeutics , Inc. , Cambridge , U . S . PATENT DOCUMENTS MA (US ) 3 ,009 , 864 A 11 / 1961 Gordon - Aldterton et al . 3 , 228 , 838 A 1 / 1966 Rinfret (72 ) Inventors : David N . Cook , Brooklyn , NY (US ) ; 3 ,608 ,030 A 11/ 1971 Grant David Arthur Berry , Brookline, MA 4 ,077 , 227 A 3 / 1978 Larson 4 ,205 , 132 A 5 / 1980 Sandine (US ) ; Geoffrey von Maltzahn , Boston , 4 ,655 , 047 A 4 / 1987 Temple MA (US ) ; Matthew R . Henn , 4 ,689 ,226 A 8 / 1987 Nurmi Somerville , MA (US ) ; Han Zhang , 4 ,839 , 281 A 6 / 1989 Gorbach et al. Oakton , VA (US ); Brian Goodman , 5 , 196 , 205 A 3 / 1993 Borody 5 , 425 , 951 A 6 / 1995 Goodrich Boston , MA (US ) 5 ,436 , 002 A 7 / 1995 Payne 5 ,443 , 826 A 8 / 1995 Borody ( 73 ) Assignee : Seres Therapeutics , Inc. , Cambridge , 5 ,599 ,795 A 2 / 1997 McCann 5 . 648 , 206 A 7 / 1997 Goodrich MA (US ) 5 , 951 , 977 A 9 / 1999 Nisbet et al. 5 , 965 , 128 A 10 / 1999 Doyle et al. ( * ) Notice : Subject to any disclaimer , the term of this 6 ,589 , 771 B1 7 /2003 Marshall patent is extended or adjusted under 35 6 , 645 , 530 B1 . 11 /2003 Borody U .
    [Show full text]
  • Erik Senneby Kappa
    Aerococcal infections - from bedside to bench and back Senneby, Erik 2018 Document Version: Förlagets slutgiltiga version Link to publication Citation for published version (APA): Senneby, E. (2018). Aerococcal infections - from bedside to bench and back. Lund University: Faculty of Medicine. Total number of authors: 1 General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. LUND UNIVERSITY PO Box 117 221 00 Lund +46 46-222 00 00 Aerococcal infections - from bedside to bench and back Erik Senneby DOCTORAL DISSERTATION by due permission of the Faculty of Medicine, Lund University, Sweden. To be defended at Segerfalkssalen, BMC, on May 24th 2018 at 13.00. Faculty opponent Associate professor Christian Giske Karolinska Institutet 1 Organization Document name LUND UNIVERSITY Doctoral dissertation Department of Clinical Sciences Date of issue Division of Infection Medicine 20180524 Author(s) Erik Senneby Sponsoring organization Title and subtitle Aerococcal Infections – from bedside to bench and back Abstract The genus Aerococcus comprises eight species of Gram-positive cocci.
    [Show full text]
  • Roles of the Vagina and the Vaginal Microbiota in Urinary Tract Infection: Evidence from Clinical Correlations and Experimental Models
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 1-1-2020 Roles of the vagina and the vaginal microbiota in urinary tract infection: Evidence from clinical correlations and experimental models Amanda L Lewis Nicole M Gilbert Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Urogenital infections and inflammations OPEN ACCESS Review Article Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models Abstract Mounting evidence indicates that the vagina can harbor uropathogenic Amanda L. Lewis1,2,3 bacteria. Here, we consider three roles played by the vagina and its Nicole M. Gilbert2,3,4 bacterial inhabitants in urinary tract infection (UTI) and urinary health. First, the vagina can serve as a reservoir for Escherichia coli, the most common cause of UTI, and other recognized uropathogens. Second, 1 Molecular Microbiology, several vaginal bacterial species are frequently detected upon urine Washington University School culture but are underappreciated as uropathogens, and other vaginal of Medicine in Saint Louis, species are likely under-reported because of their fastidious nature. United States Third, some vaginal bacteria that are not widely viewed as uropathogens 2 Obstetrics and Gynecology, can transit briefly in the urinary tract, cause injury or immunomodulation, Washington University School and shift the balance of host-pathogen interactions to influence the of Medicine in Saint Louis, outcomes of uropathogenesis. This chapter describes the current liter- United States ature in these three areas and summarizes the impact of the vaginal 3 Center for Women's microbiota on susceptibility to UTI and other urologic conditions.
    [Show full text]
  • Human Mitochondrial DNA and Endogenous Bacterial Surrogates for Risk Assessment of Graywater Reuse
    Human Mitochondrial DNA and Endogenous Bacterial Surrogates for Risk Assessment of Graywater Reuse A thesis submitted to the College of Engineering in partial fulfillment of the requirements for the Degree of Master of Science in Environmental Science From the Department of Environmental Engineering School of Energy, Environment, Medical and Biological Engineering March 24, 2014 By Brian D. Zimmerman Bachelor of Science, University of Cincinnati (2011) Advisor and Committee Chair: Dr. David Wendell Abstract Groundwater aquifers and surface waters currently used as drinking water and irrigation sources are in danger of over exploitation, leading to potable water scarcity in many regions of the world. On-site treatment and reuse of recycled wastewaters such as graywater for non- potable purposes has the ability to enhance water sustainability by alleviating demands on potable water supplies, which is particularly valuable in arid regions or in times of severe draught. However, given the inevitable downstream human contact, graywater represents a waterborne pathogen transmission and amplification pathway if human exposure to reused water is practiced without adequate treatment. Enteric pathogens are currently thought to be one of the most significant public health risks to water reuse. (1) Thus, previous studies sought to predict enteric pathogen presence in graywater through the use of fecal indicator bacteria (FIB) to indicate human fecal contamination and possible pathogen presence. However, FIB are known to grow in stored graywater, (2) do not correlate well with pathogens, (3) and may not accurately predict risks from pathogens transmitted via respiratory/oral and dermal pathways. (4) Therefore, new metrics to measure and predict microbial risk in graywater recycling systems is necessary for advancement of these systems.
    [Show full text]
  • Aerococcus Urinae and Globicatella Sanguinis
    BCI0010.1177/1178626419875089Biochemistry InsightsYu et al 875089research-article2019 Advances in Tumor Virology Aerococcus urinae and Globicatella sanguinis Persist in Volume 12: 1–15 © The Author(s) 2019 Polymicrobial Urethral Catheter Biofilms Examined in Article reuse guidelines: sagepub.com/journals-permissions Longitudinal Profiles at the Proteomic Level DOI:https://doi.org/10.1177/1178626419875089 10.1177/1178626419875089 Yanbao Yu1, Tamara Tsitrin1, Shiferaw Bekele1, Vishal Thovarai1, Manolito G Torralba2, Harinder Singh1, Randall Wolcott3, Sebastian N Doerfert4, Maria V Sizova4 , Slava S Epstein4 and Rembert Pieper1 1J. Craig Venter Institute, Rockville, MD, USA. 2J. Craig Venter Institute, La Jolla, CA, USA. 3Southwest Regional Wound Care Center, Lubbock, TX, USA. 4Northeastern University, Boston, MA, USA. ABSTRACT: Aerococcus urinae (Au) and Globicatella sanguinis (Gs) are gram-positive bacteria belonging to the family Aerococcaceae and colonize the human immunocompromised and catheterized urinary tract. We identified both pathogens in polymicrobial urethral catheter biofilms (CBs) with a combination of 16S rDNA sequencing, proteomic analyses, and microbial cultures. Longitudinal sampling of biofilms from serially replaced catheters revealed that each species persisted in the urinary tract of a patient in cohabitation with 1 or more gram-negative uropathogens. The Gs and Au proteomes revealed active glycolytic, heterolactic fermentation, and peptide catabolic energy metabolism pathways in an anaerobic milieu. A few phosphotransferase
    [Show full text]
  • Thi Na Utaliblat in Un Minune Talk
    THI NA UTALIBLATUS010064900B2 IN UN MINUNE TALK (12 ) United States Patent ( 10 ) Patent No. : US 10 , 064 ,900 B2 Von Maltzahn et al . ( 45 ) Date of Patent: * Sep . 4 , 2018 ( 54 ) METHODS OF POPULATING A (51 ) Int. CI. GASTROINTESTINAL TRACT A61K 35 / 741 (2015 . 01 ) A61K 9 / 00 ( 2006 .01 ) (71 ) Applicant: Seres Therapeutics, Inc. , Cambridge , (Continued ) MA (US ) (52 ) U . S . CI. CPC .. A61K 35 / 741 ( 2013 .01 ) ; A61K 9 /0053 ( 72 ) Inventors : Geoffrey Von Maltzahn , Boston , MA ( 2013. 01 ); A61K 9 /48 ( 2013 . 01 ) ; (US ) ; Matthew R . Henn , Somerville , (Continued ) MA (US ) ; David N . Cook , Brooklyn , (58 ) Field of Classification Search NY (US ) ; David Arthur Berry , None Brookline, MA (US ) ; Noubar B . See application file for complete search history . Afeyan , Lexington , MA (US ) ; Brian Goodman , Boston , MA (US ) ; ( 56 ) References Cited Mary - Jane Lombardo McKenzie , Arlington , MA (US ); Marin Vulic , U . S . PATENT DOCUMENTS Boston , MA (US ) 3 ,009 ,864 A 11/ 1961 Gordon - Aldterton et al. 3 ,228 ,838 A 1 / 1966 Rinfret (73 ) Assignee : Seres Therapeutics , Inc ., Cambridge , ( Continued ) MA (US ) FOREIGN PATENT DOCUMENTS ( * ) Notice : Subject to any disclaimer , the term of this patent is extended or adjusted under 35 CN 102131928 A 7 /2011 EA 006847 B1 4 / 2006 U .S . C . 154 (b ) by 0 days. (Continued ) This patent is subject to a terminal dis claimer. OTHER PUBLICATIONS ( 21) Appl . No. : 14 / 765 , 810 Aas, J ., Gessert, C . E ., and Bakken , J. S . ( 2003) . Recurrent Clostridium difficile colitis : case series involving 18 patients treated ( 22 ) PCT Filed : Feb . 4 , 2014 with donor stool administered via a nasogastric tube .
    [Show full text]
  • The Characteristics and Genome Analysis of Vb Avim AVP, the First Phage Infecting Aerococcus Viridans
    viruses Article The Characteristics and Genome Analysis of vB_AviM_AVP, the First Phage Infecting Aerococcus viridans Hengyu Xi 1,†, Jiaxin Dai 1,†, Yigang Tong 2,†, Mengjun Cheng 1, Feiyang Zhao 2, Hang Fan 2, Xinwei Li 1, Ruopeng Cai 1, Yalu Ji 1, Changjiang Sun 1, Xin Feng 1, Liancheng Lei 1, Sadeeq ur Rahman 3 , Wenyu Han 1,4,* and Jingmin Gu 1,* 1 Key Laboratory of Zoonosis Research, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130062, China; [email protected] (H.X.); [email protected] (J.D.); [email protected] (M.C.); [email protected] (X.L.); [email protected] (R.C.); [email protected] (Y.J.); [email protected] (C.S.); [email protected] (X.F.); [email protected] (L.L.) 2 State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China; [email protected] (Y.T.); [email protected] (F.Z.); [email protected] (H.F.) 3 College of Veterinary Sciences & Animal Husbandry, Abdul Wali Khan University, Mardan 23200, Pakistan; [email protected] 4 Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonose, Yangzhou University, Yangzhou 225009, China * Correspondence: [email protected] (W.H.); [email protected] (J.G.); Tel./Fax: +86-431-8783-6406 (W.H. & J.G.) † These authors contributed equally to this study. Received: 31 October 2018; Accepted: 23 January 2019; Published: 26 January 2019 Abstract: Aerococcus viridans is an opportunistic pathogen that is clinically associated with various human and animal diseases. In this study, the first identified A.
    [Show full text]
  • Fermentation Du Kivuguto, Lait Traditionnel Du Rwanda: Mise Au Point D’Un Starter Lactique
    COMMUNAUTE FRANCAISE DE BELGIQUE ACADEMIE UNIVERSITAIRE WALLONIE-EUROPE UNIVERSITE DE LIEGE GEMBLOUX AGRO-BIO TECH Fermentation du kivuguto, lait traditionnel du Rwanda: mise au point d’un starter lactique Eugène KARENZI Dissertation originale présentée en vue de l’obtention du grade de Docteur en Sciences agronomiques et Ingénierie biologique Promoteur: Pr Philippe JACQUES Co-promoteur: Pr Philippe THONART Gembloux, Janvier 2015 COMMUNAUTE FRANCAISE DE BELGIQUE ACADEMIE UNIVERSITAIRE WALLONIE-EUROPE UNIVERSITE DE LIEGE GEMBLOUX AGRO-BIO TECH Fermentation du kivuguto, lait traditionnel du Rwanda: mise au point d’un starter lactique Eugène KARENZI Dissertation originale présentée en vue de l’obtention du grade de Docteur en Sciences agronomiques et Ingénierie biologique Promoteur: Pr Philippe JACQUES Co-promoteur: Pr Philippe THONART Gembloux, Janvier 2015 Copyright. Aux termes de la loi belge du 30 juin 1994, sur le droit d'auteur et les droits voisins, seul l'auteur a le droit de reproduire partiellement ou complètement cet ouvrage de quelque façon et forme que ce soit ou d'en autoriser la reproduction partielle ou complète de quelque manière et sous quelque forme que ce soit. Toute photocopie ou reproduction sous autre forme est donc faite en violation de la dite loi et des modifications ultérieures. A Dieu Tout-Puissant Vous êtes et vous resterez toujours Grand. Amen A ma famille Merci pour la résistance et la tenue des babies hors des soucis A mon père Que cette thèse soit un prolongement de votre travail sur les fermentations traditionnelles pour la pérennisation d’une tradition familiale depuis 1400 et un couronnement de vos leçons d’Arithmétique & français sur un tableau de morceau de bois conçu par vos propres mains.
    [Show full text]
  • Impact of the MALDI-TOF As a Tool for Bacterial Identification in The
    Med Clin Pract. 2019;2(2):17–21 w ww.elsevier.es/medicinaclinicapractica Original article Impact of the MALDI-TOF as a tool for bacterial identification in the frequency of isolation of Aerococcus spp and Actinotignum schaalii in urinary tract infection a,b,∗ a,b a,b a,b a,b Nona Romaní , Gema Fernández-Rivas , Sònia Molinos , Adrián Antuori , Jun Hao Wang , a a a,b,c Natàlia Pagan , María Carrasco , Lurdes Matas a Microbiology Service, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Badalona, Spain b Universitat Autònoma de Barcelona, Spain c CIBER Epidemiologia i Salut Pública (CIBERESP), Spain a a b s t r a c t r t i c l e i n f o Article history: Background: Actinotignum schaalii and the genus Aerococcus are considered emerging pathogens, since Received 7 November 2018 their isolation has been rising the last years thanks to the improvement of diagnosis techniques, such as Accepted 9 December 2018 the implementation of MALDI-TOF in microbiology laboratories for routine. Their patogenicity is nowa- Available online 24 January 2019 days well described in urinary tract infections affecting susceptible individuals, although both have been isolated from other biological samples. The aim of our study is to evaluate the impact of using mass Keywords: spectrometry technology on the frequency of isolation of Aerococcus spp and A. schaalii in our hospital. Urinary tract infection Methods: From January 2014 and December 2015 44.654 urines were collected in our laboratory from Aerococcus spp patients that were expected to have an UTI. Samples were processed using a flow cytometer and cultured Actinotignum schaalii MALDI-TOF if applicable.
    [Show full text]
  • Aerococcus Urinae: Establishing the Pathogenesis of an Emerging Uropathogen
    Loyola University Chicago Loyola eCommons Dissertations Theses and Dissertations 2019 Aerococcus Urinae: Establishing the Pathogenesis of an Emerging Uropathogen Evann E. Hilt Follow this and additional works at: https://ecommons.luc.edu/luc_diss Part of the Microbiology Commons Recommended Citation Hilt, Evann E., "Aerococcus Urinae: Establishing the Pathogenesis of an Emerging Uropathogen" (2019). Dissertations. 3339. https://ecommons.luc.edu/luc_diss/3339 This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. Copyright © 2019 Evann E Hilt LOYOLA UNIVERSITY CHICAGO AEROCOCCUS URINAE: ESTABLISHING THE PATHOGENESIS OF AN EMERGING UROPATHOGEN A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL IN CANDIDACY FOR THE DEGREE OF DOCTOR OF PHILOSOPHY PROGRAM IN MICROBIOLOGY AND IMMUNOLOGY BY EVANN ELIZABETH HILT CHICAGO, ILLINOIS AUGUST 2019 Copyright by Evann Elizabeth Hilt, 2019 All rights reserved. ACKNOWLEDGEMENTS I would like to thank everyone that made this dissertation. First and foremost, I want to thank my mentor, Alan Wolfe. I couldn’t ask for a better mentor throughout both my masters and PhD. He created a very supportive environment in his lab and I am definitely going to miss it. I’d also like to thank the members of my dissertation committee. My committee chair Francis Alonzo for keeping our meetings moving along and asking very insightful questions. To Karen Visick and Phong Le, thank you for being co-mentors in this project and spending endless hours trying to make sense of this work.
    [Show full text]
  • Microbial Pollutants in Stagnant Water in Rr Section, Khayelitsha, Western Cape, South Africa
    MICROBIAL POLLUTANTS IN STAGNANT WATER IN RR SECTION, KHAYELITSHA, WESTERN CAPE, SOUTH AFRICA by QENEHELO ALICE LEUTA Dissertation submitted in partial fulfilment of the requirements for the degree Master of Technology: Environmental Management in the Faculty of Applied Science at the Cape Peninsula University of Technology Supervisor: Dr. A.N. Paulse Co-supervisor: Prof. J.P. Odendaal Cape Town April 2015 CPUT copyright information The dissertation may not be published either in part (in scholarly, scientific or technical journals), or as a whole (as a monograph), unless permission has been obtained from the University DECLARATION I, Qenehelo Alice Leuta, declare that the contents of this dissertation/thesis represent my own unaided work, and that the dissertation/thesis has not previously been submitted for academic examination towards any qualification. Furthermore, it represents my own opinions and not necessarily those of the Cape Peninsula University of Technology. Signed Date ii ABSTRACT Greywater is domestic wastewater from daily kitchen, laundry, bath, shower, hand washing practices and does not include wastewater from the toilet. Greywater from informal settlement has been identified as important environmental pollution sources. Inadequate sanitation and poor drainage in informal settlements result in greywater being stagnant at the base of communal taps. This water has a potential to cause health problems to those who come in contact with it. Studies of greywater quality in informal settlements in South Africa tend to concentrate on physico-chemical analysis and microbial indicator organisms. In order to adequately manage greywater in informal settlements there is a need to understand the microbial pathogens present in such water.
    [Show full text]
  • The Pathogenic Role of Actinomyces Spp. and Related Organisms in Genitourinary Infections: Discoveries in the New, Modern Diagnostic Era
    antibiotics Review The Pathogenic Role of Actinomyces spp. and Related Organisms in Genitourinary Infections: Discoveries in the New, Modern Diagnostic Era Márió Gajdács 1,2 and Edit Urbán 3,* 1 Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary; [email protected] 2 Institute of Medical Microbiology, Faculty of Medicine, Semmelweis University, 1089 Budapest, Hungary 3 Institute of Translational Medicine, Faculty of Medicine, University of Pécs, 7624 Pécs, Hungary * Correspondence: [email protected] or [email protected]; Tel.: +36-62-536-246 Received: 20 June 2020; Accepted: 15 August 2020; Published: 17 August 2020 Abstract: Actinomycosis is a chronic, suppurative, granulomatous infectious disease, caused by different species of Actinomyces bacteria. To date, 26 validly published Actinomyces species have been described as part of a normal human microbiota or from human clinical specimens. Due to the rapid spread of new, modern diagnostic procedures, 13 of 26 of these species have been described in this century and the Actinomycetaceae family has undergone several taxonomic revisions, including the introduction of many novel species termed Actinomyces-like organisms (ALOs). There is scarce data available on the role of these novel bacterial species in various infectious processes in human medicine. The aim of this review is to provide a comprehensive overview of Actinomyces and closely related organisms involved in human diseases—with a special focus on newly described species—in particular their role in genitourinary tract infections in females and males. Keywords: Actinomyces; Actinomyces-like organisms; Actinotignum; anaerobe; MALDI-TOF MS; sequencing; genitourinary; taxonomy 1. Introduction, Taxonomy of Actinomyces and Closely Related Species Actinomycosis is a chronic, suppurative, granulomatous infectious disease, caused by different species of Actinomyces bacteria [1,2].
    [Show full text]